Praxis Precision Medicines Provides Regulatory Update On PRAX-114 Program
CAMBRIDGE, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a…
CAMBRIDGE, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a…
Board Member Brian Shure will join executive team as Chief Financial OfficerSteve Neil will remain…
ROCKVILLE, Md., Nov. 09, 2020 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a pharmaceutical…
Company delivers strong results despite being adversely affected by California Wildfires Vertically-integrated California cannabis leader…
– Firdapse® Third Quarter Net Revenues of $29.2 Million – Company Ends Third Quarter with…
ROCKVILLE, MD, Nov. 09, 2020 (GLOBE NEWSWIRE) —  MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical…
SAN DIEGO, Nov. 09, 2020 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced…
CAMBRIDGE, Mass, Nov. 09, 2020 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology…
Product revenue for the first nine months of 2020 increased 29% year-over-year to $30.8 million…
NEW YORK, Nov. 09, 2020 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX) today announced…
CHATHAM, N.J., Nov. 09, 2020 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix…
Sydney, Australia, Nov. 10, 2020 (GLOBE NEWSWIRE) — ASX/Media Release                                                                                                                    Overall Response Rates (ORR)…
VERSATILE-002 Trial for First Line Treatment of Recurrent/Metastatic Head and Neck Cancer with Combination PDS0101-KEYTRUDA®…
SOUTH SAN FRANCISCO, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) — Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical…
Expansion in international and seed treatment markets led revenue growth and gross margin improvement DAVIS,…
SANTA CLARA, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (Nasdaq: SWAV), a…
GAITHERSBURG, Md., Nov. 09, 2020 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical…
CANTON, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading…
Conference call scheduled for Tuesday, November 10, 2020 at 8:30 a.m. ET NEW YORK and…
– Based on Positive Data, Advancing pheNIX Gene Therapy Clinical Trial for PKU to Dose…